Follow-up examination after treatment for conditions other than malignant neoplasms

MESH PheWeb

Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 Z09

Cause of death: ICD-10 Z09

19408

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10 ; C.O.D: 10

19408

Check minimum number of events None

19408

Include endpoints None

19408

Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF4

Parent code in ICD-10 Z[0-1]

Similar endpoints

↥

List of similar endpoints to Follow-up examination after treatment for conditions other than malignant neoplasms based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	18820	15348	3472
Unadjusted prevalence (%)	6.10	8.84	2.57
Mean age at first event (years)	49.54	48.27	55.15

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.61 [1.31, 1.98]	5.9e-6	891
15 years	0.01	1.10 [0.90, 1.34]	3.4e-1	469
5 years	0.00	1.88 [1.53, 2.31]	2.4e-9	241
1 year	0.00	3.41 [2.54, 4.57]	2.4e-16	84

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS – Follow-up examination after treatment for conditions other than malignant neoplasms
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Follow-up examination after treatment for conditions other than malignant neoplasms
after Follow-up examination after treatment for conditions other than malignant neoplasms

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Follow-up examination after treatment for conditions other than malignant neoplasms

↥